Cargando…
1788. Cost-Effectiveness of Penicillin Skin Testing Among Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin Allergy
BACKGROUND: Methicillin sensitive Staphylococcus aureus (MSSA) bacteremia is a highly lethal infection; first-line therapy with a β-lactam, commonly cefazolin, provides a significant mortality benefit over the second-line therapy, vancomycin, which is often used in patients reporting β-lactam allerg...
Autores principales: | Vaisman, Alon, Chambers, Henry F, Winston, Lisa G, Kazi, Dhruv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253399/ http://dx.doi.org/10.1093/ofid/ofy210.1444 |
Ejemplares similares
-
1216. Cost-Effectiveness of Penicillin Skin Allergy Testing in Methicillin-Sensitive Staphylococcus aureus (MSSA) Bacteremia
por: Meninger, Stephen, et al.
Publicado: (2018) -
The Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia
por: Blumenthal, Kimberly G., et al.
Publicado: (2016) -
Penicillin skin testing in methicillin-sensitive staphylococcus aureus bacteremia: A cost-effectiveness analysis
por: Mattingly, T. Joseph, et al.
Publicado: (2019) -
301. Penicillin Versus Cefazolin or Anti-staphylococcal Penicillins for Penicillin-Susceptible Staphylococcus aureus Bacteremia
por: Aldhaeefi, Mohammed, et al.
Publicado: (2020) -
The Cost-effectiveness of Cefazolin Compared With Antistaphylococcal Penicillins for the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia
por: Pliakos, Elina Eleftheria, et al.
Publicado: (2021)